Eli Lilly says it will file for approval of next-generation obesity drug in 2027 as it clears two more trials
--------------------------------------------------------------------
Source: CNBC
Published: 2026-07-23 20:45 UTC+10:00
Section: General
Factuality Score: 92
Opinion Category: Neutral
Topics: Health, Drugs
--------------------------------------------------------------------
Snippet:
Eli Lilly on Thursday said it will file for approval of its next-generation obesity drug in the first quarter of 2027, as the treatment succeeds in two more late-stage trials.
--------------------------------------------------------------------